Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-tubulin complex component 4 (TUBGCP4) is a protein encoded by the TUBGCP4 gene that forms part of the gamma-tubulin ring complex (γTuRC), a multi-protein structure essential for microtubule nucleation at the centrosome in mammalian cells. This process is critical for minus-end nucleation of alpha-beta tubulin heterodimers, spindle assembly, and centrosome duplication during cell division. The protein features a structure of five helical bundles, with a C-terminal domain that directly binds gamma-tubulin. Mutations in TUBGCP4 have been associated with autosomal recessive microcephaly and chorioretinopathy. The gene undergoes alternative splicing and has important paralogs such as TUBGCP6. There are currently no approved drugs that directly target TUBGCP4, nor is it established as a clinical biomarker or direct therapeutic target; nevertheless, its central role in microtubule organization links it to cellular processes relevant to diseases such as developmental disorders and potentially cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-tubulin complex component 4 (TUBGCP4).